Introducing MinaBella
MinaBella has 3 different product lines so it can be strategically injected in the right areas and gives volume to the skin.

* HA derivatives with concentrations adjusted are ground in plunger mills to produce different particle sizes.
Product Composition
Each product packaged into a box contains two needles.


* Two needles of different sizes are contained in each pack, allowing practitioners to select the size based on user convenience.
Product Characteristics
MinaBella is hyaluronic acid (HA) fillers characterized by its biphasic structures.

- Particle-based type
- High elasticity & Low viscosity
- Stable injection force with good adhesion
- Excellent volumizing effect
- Major products: MinaBella, Restylane, Yvoire


Clinical Data

- More Safe
- More Elastic
- More Long-Lasting
- More Natural
- More Smooth
Results of BDDE use
Comparison with other products

Residual BDDE
Comparison with other products

No residual BDDE was detected.
Measurement of elastic modulus (G’)
Comparison with other products

Durability of the filler after HA crosslinking
Comparison with other products

Evaluation of Adhesion Performance (Tack Value)

Excellent adhesion performance enables procedure tailored to the need of individual customers, resulting in natural appearance and preventing displacement of fillers after procedure.
Comparative Evaluation of Adhesion Performance (Tack Value)
Comparison with other products

Comparative Evaluation of Injection Force
Comparison with other products

Introducing Sodium Hyaluronate Technology by Hyundai BIOLAND
Hyundai BIOLAND is a global supplier of HA fillers with over 30 years of track record for production of cosmetic, food and medical purposes, which started from the first product development of HA in Korea based on fermentation and cell culture technology.
Marketing
- 1982 AMORE PACIFIC (former Taepyeongyang Chemical Industrial Corp.) succeeded in the first product development of HA in Korea
- 2004 Took over Biochemistry Division(Ansan Plant) of Taepyeongyang Chemical Industrial Corp.
- Development of HA production technology for pharmaceutical/medical device/cosmetic/food sectors
- Fermentation and cell culture technologies: Over 200 bacterial strains including Streptococcus equi subsp.(for HA)
- Contained in bio cellulose mask pack, SC-glucan and fermentation-based cosmetics
- Non-GMO
Sector-specific HA Products
Medical Devices
HA fillers, injections for knee joints, etc. (A company, C company, Ch company, etc.)Cosmetics
Ingredients for moisturizing effect for cosmetic products (Lancôme, Dior, La Roche-Posay, L’Oréal, etc.)Food
Ingredients of functional foods for skin health (Kolmar, Cosmax Bio, LG H&H, etc.)
Equipped with the largest GMP-compliant production capacity (500kg) in Korea,
HA fillers of high quality are produced through rigorous controls of bacterial strains and the overall process control for manufacturing operations.

With controls of materials, process and product quality in compliance with ISO 13485 quality management system, consistent lot-to-lot quality and performance of HA end products are ensured in terms of molecular weight, viscosity and endotoxin levels.
